Gynecologic Cancer Immunotherapy: New potential in gynecologic cancers

2 Views

07/08/23

Globally, ovarian cancer is diagnosed in an estimated 300,000 women each year—and another 570,000 are diagnosed with cervical cancer and 382,000 with uterine (endometrial) cancer. While significant advances have been made in surgical and chemo-based treatments for ovarian cancer, the survival rates have only modestly improved. Immunotherapy for ovarian cancer shows tremendous potential for addressing this devastating disease. In this session, Dr. Kunle Odunsi, director of the University of Chicago Medicine Comprehensive Cancer Center, will discuss details of immunotherapy clinical trials in ovarian cancer currently underway and take your questions about new treatments in gynecologic cancers.